CNSA is an organization of clinical & academic neurologists dedicated to neurology & the neurosciences.
Joined January 2020
- Tweets 1,294
- Following 203
- Followers 434
- Likes 200
992 Photos and videos
Interested in becoming a member of CNSA? CNSA's mission is to improve clinical practice and patient care through education and thought leadership.
Join or renew here: bit.ly/3okHSCl
14
1
25
Today is #WorldBrainTumorAwarenessDay!
Today is a reminder to take unusual brain-related symptoms seriously.
Learn more from @PSRIHospital: bit.ly/4x0lYXt
17
Today is #TouretteSyndromeAwarenessDay!
#DYK? #TS is part of a spectrum of hereditary, childhood-onset, neurodevelopmental conditions referred to as Tic Disorders.
Learn more from @TouretteAssn: bit.ly/4wRBaGa
1
134
To improve care for those with epilepsy, particularly those with difficult to diagnose and drug-resistant epilepsy, patients need more access to specialized care, including #EMUs.
Read more: bit.ly/4c3VeNP
24
#AlzheimersDisease is distinguished from other forms of dementia by deposition and accumulation of two proteins in certain areas of the brain, such as:
π’ Amyloid-beta
π’ Tau
Read more: bit.ly/3YSNTs9
1
41
π
SAVE THE DATE for #CN27 in San Juan, Puerto Rico!
π More information on the conference coming soon.
π Look for updates here: bit.ly/3PwQDLe
32
#DYK? #CAE was originally considered a βbenignβ type of epilepsy due to its high frequency of remission and because absence seizures are relatively easily controlled compared to seizures seen in other types of epilepsy.
Read more: bit.ly/4bvco3l
36
π
SAVE THE DATE for #CN27 in San Juan, Puerto Rico!
π More information about the conference coming soon.
π In the meantime, view the #CN26 program: bit.ly/427TbSg
20
Interested in becoming a member of CNSA? CNSA's mission is to improve clinical practice and patient care through education and thought leadership.
Join or renew here: bit.ly/3okHSCl
23
#DYK? #Alzheimers has three broad stages, including:
π’ Preclinical
π’ Mild-cognitive impairment
π’ Dementia
Learn more: bit.ly/3YSNTs9
42
The CIDP Ambassador Program, a collaboration between CNSA and Grifols, is an educational program on improving the recognition, diagnosis and treatment of #CIDP.
Applications for the 2026 program are opening soon!
Stay tuned & learn more: bit.ly/4eCLsR3
150
CNSA's goal is to improve clinical practice and patient care through education and thought leadership.
Learn more about the society: bit.ly/2V0P3V7
2
40
The CIDP Ambassador Program, a collaboration between CNSA and Grifols, is an educational program on improving the recognition, diagnosis and treatment of #CIDP.
Applications for the 2026 program are opening soon!
Stay tuned & learn more: bit.ly/4eCLsR3
586
Raymond Scott Turner, MD, PhD, talks about the diagnostic tools in part two of CNSA's six-part video series about Alzheimer's disease.
Watch to learn more: bit.ly/43d0QR7
41
The underlying cause of #AIP is a genetic mutation in the pathway used to synthesize heme.
Watch to learn more about acute intermittent porphyria: bit.ly/4p9DSTo
56
FDA's Breakthrough Therapy program facilitates the development of innovative medications that show the potential to provide substantially better outcomes than what patients experience with existing medications.
Read more: bit.ly/3KOPxpm
20
Marissa Natelson-Love, MD, talks about pre-diagnosis in part one of CNSA's six-part video series about Alzheimer's disease.
Watch to learn more: bit.ly/3St4obx
35
CNSA's webinar, "Minimizing the Devastating Impact of Synucleinopathies," highlights the utility of biomarker testing in enabling early diagnosis and appropriate treatment of symptoms.
Watch to learn more: bit.ly/4hhG0UW
48